CpG-induced IFN-α production of plasmacytoid dendritic cells: Time and dosage dependence and the effect of structural modifications to the CpG backbone

Nucleic Acid Therapeutics

Volumn 23, Issue 2, 2013, Pages 118-124

  Jeske, Sabrina ^a   Pries, Ralph ^a   Wollenberg, Barbara ^a  

^a University of Schleswig Holstein Campus ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CPG OLIGODEOXYNUCLEOTIDE;

ARTICLE; CELL SELECTION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; KINETICS; NORMAL HUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN MODIFICATION; SECRETION RATE; SEQUENCE ANALYSIS;

B-LYMPHOCYTES; CPG ISLANDS; CYTOSINE; DENDRITIC CELLS; GUANOSINE; HUMANS; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; OLIGODEOXYRIBONUCLEOTIDES; PHOSPHATES;

EID: 84876266706     PISSN: 21593337     EISSN: None     Source Type: Journal    
DOI: 10.1089/nat.2012.0384     Document Type: Article

References (36)

1. BERNIER, J., REUTER, A., VRINDTS-GEVAERT, Y., and FRANCHIMONT, P. (1984). Radioimmunoassay of leukocyte (alpha) interferon and its application to some clinical conditions. J. Nucl. Med. 25, 765-772.
2. CELLA, M., FACCHETTI, F., LANZAVECCHIA, A., and COLONNA, M. (2000). Plasmacytoid dendritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat. Immunol. 1, 305-310.
3. DALPKE, A.H., ZIMMERMANN, S., ALBRECHT, I., and HEEG, K. (2002). Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo. Immunology 106, 102-212.
4. DE WIT, D., OLISLAGERS, V., GORIELY, S., VERMEULEN, F., WAGNER, H., GOLDMAN, M., and WILLEMS, F. (2004). Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood 103, 1030-1032.
5. DURAMAD, O., FEARON, K.L., CHAN, J.H., KANZLER, H., MARSHALL, J.D., COFFMAN, R.L., and BARRAT, F.J. (2003). IL-10 regulates plasmacytoid dendritic cell response to CpGcontaining immunostimulatory sequences. Blood 102, 4487-4492.
6. GARY-GOUY, H., LEBON, P., and DALLOUL, A.H. (2002). Type 1 interferon production by plasmacytoid dendritic cells and monocytes is triggered by viruses, but the level of production is controlled by distinct cytokines. J. Interferon Cytokine Res. 22, 653-639.
7. GRAU, G.E., ROUX-LOMBARD , P., GYSLER, C., LAMBERT, C., LAMBERT, P.H., DAYER, J.M., and GUILLEVIN, L. (1989). Serum cytokine changes in systemic vasculitis. Immunology 68, 196-198.
8. GUIDUCCI, C., OTT, G., CHAN, J.H., DAMON, E., CALACSAN, C., MATRAY, T., LEE, K.D., COFFMAN, R.L., and BARRAT, F.J. (2006). Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation. J. Exp. Med. 203, 1999-2008.
9. HAAS, T., SCHMITZ, F., HEIT, A., and WAGNER, H. (2009). Sequence independent interferon-alpha induction by multimerized phosphodiester DNA depends on spatial regulation of Toll-like receptor-9 activation in plasmacytoid dendritic cells. Immunology 126, 290-298.
10. HARTMANN, E., WOLLENBERG, B., ROTHENFUSSER, S., WAGNER, M., WELLISCH, D., MACK, B., GIESE, T., GIRES, O., ENDRES, S., and HARTMANN, G. (2003). Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Res. 63, 6478-6487.
11. HARTMANN, G., BATTIANY, J., POECK, H., WAGNER, M., KERKMANN, M., LUBENOW, N., ROTHENFUSSER, S., and ENDRES, S. (2003). Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells. Eur. J. Immunol. 33, 1633-1641.
12. HARTMANN, G., KRUG, A., WALLER-FONTAINE, K., and ENDRES, S. (1996). Oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor: dependence on phosphorothioate modification and reversal by heparin. Mol. Med. 2, 429-438.
13. KRIEG, A.M. (2006). Therapeutic potential of Toll-like receptor 9 activation. Nat. Rev. Drug Discov. 5, 471-484.
14. KRIEG, A.M., YI, A.K., MATSON, S., WALDSCHMIDT, T.J., BISHOP, G.A., TEASDALE, R., KORETZKY, G.A., and KLINMAN, D.M. (1995). CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546-549.
15. KRUG, A., ROTHENFUSSER, S., HORNUNG, V., JAHRSDORFER, B., BLACKWELL, S., BALLAS, Z.K., ENDRES, S., KRIEG, A.M., and HARTMANN, G. et al. (2001). Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur. J. Immunol. 31, 2154-2163.
16. KRUG, A., TOWAROWSKI, A., BRITSCH, S., ROTHENFUSSER, S., HORNUNG, V., BALS, R., GIESE, T., ENGELMANN, H., ENDRES, S., KRIEG, A.M., and HARTMANN, G. (2001). Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 31, 3026-3037.
17. LATZ, E., SCHOENEMEYER, A., VISINTIN, A., FITZGERALD, K.A., MONKS, B.G., KNETTER, C.F., LIEN, E., NILSEN, N.J., ESPEVIK, T. and GOLENBOCK, D.T. (2004). TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 5, 190-198.
18. LEIFER, C.A., KENNEDY, M.N., MAZZONI, A., LEE, C., KRUHLAK, M.J., and SEGAL, D.M. (2004). TLR9 is localized in the endoplasmic reticulum prior to stimulation. J. Immunol. 173, 1179-1183.
19. LIANG, H., NISHIOKA, Y., REICH, C.F., PISETSKY, D.S., and LIPSKY, P.E. (1996). Activation of human B cells by phosphorothioate oligodeoxynucleotides. J. Clin. Invest. 98, 1119-1129.
20. LIU, Y.J. (2005). IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23, 275-306.
21. MENDE, M., HOPERT, A., WUNSCHE, W., OVERHOFF, M., DETZER, A., BORNGEN, K., SCHLENKE, P., KIRCHNER, H., and SCZAKIEL, G. (2007). A hexanucleotide selected for increased cellular uptake in cis contains a highly active CpGmotif in human B cells and primary peripheral blood mononuclear cells. Immunology 120, 261-272.
22. MOSEMAN, E.A., LIANG, X., DAWSON, A.J., PANOSKALTSISMORTARI, A., KRIEG, A.M., LIU, Y.J., BLAZAR, B.R., and CHEN, W. (2004). Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+ CD25 + regulatory T cells. J. Immunol. 173, 4433-4442.
23. PEREZ, J.R., LI, Y., STEIN, C.A., MAJUMDER, S., VAN OORSCHOT, A., and NARAYANAN, R. (1994). Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides. Proc. Natl. Acad. Sci. U. S. A. 91, 5957-5961.
24. RISSOAN, M.C., SOUMELIS, V., KADOWAKI, N., GROUARD, G., BRIERE, F., DE WAAL MALEFYT, R., and LIU, Y.J. (1999). Reciprocal control of T helper cell and dendritic cell differentiation. Science 283, 1183-1186.
25. ROCKWELL, P., O'CONNOR, W.J., KING, K., GOLDSTEIN, N.I., ZHANG, L.M., and STEIN C.A, (1997). Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides. Proc. Natl.Acad. Sci. U. S. A. 94, 6523-6528.
26. STAEHELIN, T., STAHLI, C., HOBBS, D.S., and PESTKA, S. (1981). A rapid quantitative assay of high sensitivity for human leukocyte interferon with monoclonal antibodies. Methods Enzymol. 79, 589-595.
27. STOUT-DELGADO, H.W., YANG, X., WALKER, W.E., TESAR, B.M., and GOLDSTEIN, D.R. (2008). Aging impairs IFN regulatory factor 7 up-regulation in plasmacytoid dendritic cells during TLR9 activation. J. Immunol. 181, 6747-6756.
28. TEMSAMANI, J., KUBERT, M., TANG, J., PADMAPRIYA, A., and AGRAWAL, S. (1994). Cellular uptake of oligodeoxynucleotide phosphorothioates and their analogs. Antisense. Res. Dev. 4, 35-42.
29. TVERSKY, J.R., LE, T.V., BIENEMAN, A.P., CHICHESTER, K.L., HAMILTON, R.G., and SCHROEDER, J.T. (2008). Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon-alpha via Toll-like receptor 9. Clin. Exp. Allergy 38, 781-788.
30. VOLLMER, J., WEERATNA, R., PAYETTE, P., JURK, M., SCHETTER, C., LAUCHT, M., WADER, T., TLUK, S., LIU, M., DAVIS, H.L., and KRIEG, A.M. (2004). Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur. J. Immunol. 34, 251-262.
31. WANG, W., CHEN, H.J., SCHWARTZ, A., CANNON, P.J., STEIN, C.A., and RABBANI, L.E. (1996). Sequence-independent inhibition of in vitro vascular smooth muscle cell proliferation, migration, and in vivo neointimal formation by phosphorothioate oligodeoxynucleotides. J. Clin. Invest. 98, 443-450.
32. WEIDLE, U., and WEISSMANN, C. (1983). The 5¢-flanking region of a human IFN-alpha gene mediates viral induction of transcription. Nature 303, 442-446.
33. WU, P., WU, J., LIU, S., HAN, X., LU, J., SHI, Y., WANG, J., LU, L., and CAO, X. (2008). TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients. Clin. Immunol. 129, 40-48.
34. YUEN, A.R., and SIKIC, B.I. (2000). Clinical studies of antisense therapy in cancer. Front Biosci. 5, D588-593.
35. ZEUZEM, S., WELSCH, C., and HERRMANN, E. (2003). Pharmacokinetics of peginterferons. Semin Liver Dis. 23, 23-28.
36. ZHAO, Q., MATSON, S., HERRERA, C.J., FISHER, E., YU, H., and KRIEG, A.M. (1993). Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides. Antisense Res. Dev. 3, 53-66.